(Reuters) – The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s Keytruda for a hard-to-treat form of bladder cancer, making it the first new treatment for the cancer in more than two decades. The therapy was approved for patien... More »
(Reuters) – Merck & Co (MRK.N) said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income cou... More »
(Corrects April 27 story in paragraph 10 to say production at a plant in Belgium is planned to start in 2019, and sales are planned to begin in 2020.) By Joseph White ZHANGJIAKOU, China (Reuters) – While auto workers in Germany and South Korea fight to save th... More »
FILE PHOTO: A Heinz Ketchup bottle and a bottle of Kraft parmesan cheese are displayed in a grocery store in New York March 25, 2015. REUTERS/Eduardo Munoz (Reuters) – Kraft Heinz Co’s (KHC.O) quarterly profit and sales missed analysts’ estimates on Friday, hu... More »
LOS ANGELES (Reuters) – Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer. Shares of Merck have fallen 10... More »
Merck & Co (MRK.N) on Friday said quarterly sales of its Keytruda cancer immunotherapy exceeded $1 billion for the first time, but it withdrew an application for European use of the drug in lung cancer, raising questions about future sales. More »
Giving Merck & Co's immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to provide durable benefits, according to an update of a closely watched clinical trial. More »
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck’s pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky Merck & ... More »
Merck & Co Inc said on Tuesday it had got a nod from the U.S. Food and Drug Administration for its already-approved immunotherapy drug Keytruda as a treatment for a type of blood cancer. More »
Activist hedge fund Elliott Management Corp said on Friday it had entered into a standstill agreement with U.S. healthcare services company Advisory Board Co. More »
Merck & Co Inc said on Tuesday it will halt a late-stage trial of an Alzheimer’s drug after it was determined that it had no chance of working, marking the latest in a long line of crushing disappointments in efforts to find an effective treatment for the mind... More »
Out of fuel signs are pictured on gas pumps at a Mapco gas station at Spence Lane and Lebanon Pike in Nashville, Tennessee, U.S. September 17, 2016. REUTERS/David Mudd Retail gasoline prices surged due to continuing problems with Colonial Pipeline Co’s gasolin... More »
Gannett Co Inc (GCI.N), the publisher of USA Today, raised its unsolicited offer for Tribune Publishing Co (TPUB.N) to $15 per share from $12.25, valuing the publisher of the Chicago Tribune and the Los Angeles Times at about $475 million. Including debt, the ... More »
Gannett Co Inc (GCI.N), the publisher of USA Today, raised its all-cash offer to buy Tribune Publishing Co (TPUB.N) to $15 per share from $12.25, valuing the publisher of the Chicago Tribune and the Los Angeles Times at about $864 million. Tribune’s shares wer... More »
NEW YORK Oaktree Capital Management urged newspaper publisher Tribune Publishing to negotiate a merger with Gannett Co Inc after it declined a purchase offer by Gannett, Barron’s reported, citing 13D filings from May 5-11. Oaktree holds 14.8 percent of Tribune... More »
SAN JOSE, Calif.,/NEW YORK A federal jury on Thursday ordered Gilead Sciences Inc (GILD.O) to pay Merck & Co (MRK.N) $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C. The damages award is far less than the $2... More »
Gannett Co Inc (GCI.N), the publisher of USA Today, said on Thursday it would bring its local and national publications under the USA Today Network. Gannett was separated from its broadcasting and digital arm, Tegna Inc (TGNA.N), in June and the new brand mark... More »
Merck & Co’s drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug Administration said. The drug, which goes by the chemical name of sugammadex, has repe... More »
Gannett Co Inc, publisher of USA Today, said on Wednesday it will buy Journal Media Group for $280 million. The price of $12 a share represents an almost 45 percent premium to Journal Media’s closing share price of $8.29 Tysons Corner, Virginia-based Gannett s... More »
The U.S. Food and Drug Administration on Friday approved Merck & Co Inc’s immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker. The FDA approval for Keytruda in advanced non-small cell... More »
